Medications for Opioid Use Disorder: Patients’ Experience, Knowledge, and Preferences in the Era of Illicitly Manufactured Fentanyl

Despite IMF impacting withdrawal, cravings, and MOUD decision making, most patients felt MOUD managed symptoms well. Experiences with alternative buprenorphine initiations were positive. Access to low-barrier treatment with immediate medication initiation, aggressive dose escalation, office-based treatment, and peer-based messaging around MOUD may increase treatment uptake.